Hematologic Malignancies Testing Market Trend, Forecast, Drivers, Restraints, Company Profiles and Key Players Analysis by 2027
Hematologic
Malignancies Testing Market,’ published by Emergen Research, provides the
reader with a comprehensive view of the global Hematologic Malignancies Testing
industry, acquainting them with the latest market trends, industry insights,
and market share. The report provides an in-depth investigation of the global
market, largely focusing on each segment and sub-segment of the Hematologic
Malignancies Testing market.
According to the
current analysis by Emergen Research, the Global Hematologic
Malignancies Testing Market size is expected
to reach USD 5.45 Billion in terms of revenue from USD 1.95 Billion in 2019,
delivering a CAGR of 14.6% through 2027.
To get leading
market solutions, visit the link below:
https://www.emergenresearch.com/industry-report/hematologic-malignancies-testing-market
A
SWOT analysis is performed on the leading companies engaged in the Hematologic
Malignancies Testing market to offer a better understanding of the strengths,
opportunities, weaknesses, and threats of the leading companies. It also covers
production and consumption rate, the volatility of prices and demands, market
share, market size, global position, and market position of each player
Key
players in the global hematologic malignancies testing market are ArcherDx,
Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., Invitae Corporation,
Abbott Laboratories, NeoGenomics Laboratories, Inc., Cancer Genetics Inc.,
Asuragen, Inc., Invivoscribe, Inc., and Adaptive Biotechnologies Corporation,
among others.
Key
Highlights From Report
In March 2020, Sysmex
Corporation, a leading diagnostic solutions company, received Japan marketing
clearance for the world's largest genome research organization, BGI Group’s coronavirus
kit distribution. This initiative strengthened the company’s position in
Japan.
Emergen Research
has segmented the Global Hematologic Malignancies Testing Market on the basis
of product, technology, disease, end-use, and region:
·
Regional Outlook (Revenue, USD Billion; 2017-2027)
o
North America
1.
U.S.
2.
Canada
3.
Mexico
o
Europe
1.
Germany
2.
U.K.
3.
France
4.
BENELUX
5.
Rest of Europe
o
Asia Pacific
1.
China
2.
Japan
3.
South Korea
4.
India
5.
Rest of APAC
o
Latin America
1.
Brazil
2.
Rest of LATAM
o
Middle East & Africa
1.
Saudi Arabia
2.
U.A.E.
3.
Rest of MEA
Contact Us:
Corporate Sales Specialist
Emergen
Research | Web: www.emergenresearch.com
Direct
Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Comments
Post a Comment